|
|
Insmed Incorporated
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: Dupixent just crashed our parade. I think our "parade" is still intact. 1st - Theirs is a $ 3,500 injectable. 2nd - Our phase 2 results are better than their P-3 results on exasperations. Recent Insmed conferences have indicated P-3 is going better than our P-2. 3rd - Their trial was for severe COPD, not Bronc. Our realistic (potential) market is bigger than theirs. 4th - What and how what ours does is different than what theirs does. 5th - They have a long list of potential adverse reaction warnings. |
||||||||||||
|
|
return to message board, top of board |
